Thailand · Delayed Price · Currency is THB HashiCorp Statistics
Total Valuation
BKK:KLINIQ has a market cap or net worth of THB 5.15 billion. The enterprise value is 4.87 billion.
| Market Cap | 5.15B |
| Enterprise Value | 4.87B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Apr 29, 2025 |
Share Statistics
BKK:KLINIQ has 220.00 million shares outstanding.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 65.86% |
| Owned by Institutions (%) | 1.42% |
| Float | 62.92M |
Valuation Ratios
The trailing PE ratio is 15.52 and the forward PE ratio is 13.58. BKK:KLINIQ's PEG ratio is 1.36.
| PE Ratio | 15.52 |
| Forward PE | 13.58 |
| PS Ratio | 1.66 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 2.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.36 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.11, with an EV/FCF ratio of 24.61.
| EV / Earnings | 14.68 |
| EV / Sales | 1.57 |
| EV / EBITDA | 7.11 |
| EV / EBIT | 11.67 |
| EV / FCF | 24.61 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.35.
| Current Ratio | 1.42 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 0.94 |
| Debt / FCF | 3.24 |
| Interest Coverage | 16.94 |
Financial Efficiency
Return on equity (ROE) is 18.43% and return on invested capital (ROIC) is 10.93%.
| Return on Equity (ROE) | 18.43% |
| Return on Assets (ROA) | 8.21% |
| Return on Invested Capital (ROIC) | 10.93% |
| Return on Capital Employed (ROCE) | 17.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.98 |
| Inventory Turnover | 5.49 |
Taxes
In the past 12 months, BKK:KLINIQ has paid 75.62 million in taxes.
| Income Tax | 75.62M |
| Effective Tax Rate | 18.56% |
Stock Price Statistics
The stock price has decreased by -38.01% in the last 52 weeks. The beta is -0.14, so BKK:KLINIQ's price volatility has been lower than the market average.
| Beta (5Y) | -0.14 |
| 52-Week Price Change | -38.01% |
| 50-Day Moving Average | 22.32 |
| 200-Day Moving Average | 28.11 |
| Relative Strength Index (RSI) | 51.85 |
| Average Volume (20 Days) | 323,669 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:KLINIQ had revenue of THB 3.11 billion and earned 331.71 million in profits. Earnings per share was 1.51.
| Revenue | 3.11B |
| Gross Profit | 1.61B |
| Operating Income | 417.50M |
| Pretax Income | 407.36M |
| Net Income | 331.71M |
| EBITDA | 555.17M |
| EBIT | 417.50M |
| Earnings Per Share (EPS) | 1.51 |
Balance Sheet
The company has 939.31 million in cash and 641.87 million in debt, giving a net cash position of 297.44 million or 1.35 per share.
| Cash & Cash Equivalents | 939.31M |
| Total Debt | 641.87M |
| Net Cash | 297.44M |
| Net Cash Per Share | 1.35 |
| Equity (Book Value) | 1.82B |
| Book Value Per Share | 8.19 |
| Working Capital | 401.45M |
Cash Flow
In the last 12 months, operating cash flow was 657.60 million and capital expenditures -459.68 million, giving a free cash flow of 197.91 million.
| Operating Cash Flow | 657.60M |
| Capital Expenditures | -459.68M |
| Free Cash Flow | 197.91M |
| FCF Per Share | 0.90 |
Margins
Gross margin is 51.76%, with operating and profit margins of 13.43% and 10.67%.
| Gross Margin | 51.76% |
| Operating Margin | 13.43% |
| Pretax Margin | 13.10% |
| Profit Margin | 10.67% |
| EBITDA Margin | 17.86% |
| EBIT Margin | 13.43% |
| FCF Margin | 6.37% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 5.76%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 5.76% |
| Dividend Growth (YoY) | 7.69% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 92.85% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.76% |
| Earnings Yield | 6.44% |
| FCF Yield | 3.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BKK:KLINIQ has an Altman Z-Score of 4.7 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.7 |
| Piotroski F-Score | 5 |